The boardroom on the fourteenth floor had a view of the harbor that made you feel like whatever happened in here was important. Claire had always thought so. Now, standing at the head of the table while eleven people arranged themselves in leather chairs, she thought it looked like a stage set for a verdict.
Dr. Prewitt sat at the center, her reading glasses on a chain around her neck. Mark sat to her right, jacket already off, sleeves rolled, a laptop open in front of him. Ruth Chen from legal. Two trustees Claire had never met. And a seat empty on the other side of the room—reserved, she realized, for Ethan, who came in five minutes late and took it without apology.
"You asked for fifteen minutes," Prewitt said. "You have it."
Claire passed the folders down the table. Twelve pages. Reyes's clinical review on top, his signature in blue ink.
"CardioSense is deployed in fourteen hospitals," she said. "The algorithm flags patients for elevated cardiac risk. It was validated on a sample that was seventy-eight percent male. When it runs in the field, it flags low-risk for thirty-one percent of women with acute cardiac events. Four percent of men."
She let the number sit.
"Dr. Reyes reviewed the raw deployment data independently. Seventeen women in that flagged group had events within ninety days. Two died."
"Allegedly," Mark said, without looking up from his laptop.
"They're not allegations, Mark. They're in the deployment logs."
"Logs you obtained after a data-access lockdown. Logs that, according to our audit, were exported to a personal device at 11:42 p.m. on a Tuesday." He turned the laptop so Prewitt could see the screen. "I'd like to discuss the provenance of this report before we discuss its contents."
Prewitt's face didn't move. "Ms. Bennett?"
"I received the data from a source. I verified it against the trial release. The numbers are consistent."
"The numbers are consistent with a file someone assembled," Mark said. "We have no chain of custody. We have a former employee's personal email—" he clicked, and the projector woke up, and Claire's stomach dropped, because she knew what was on the screen before the words resolved— "sent from a personal account to a Boston Globe address, two days before the Globe ran their story. Nadia Alvarez. The same reporter."
The room went very quiet.
"Claire," Prewitt said. "Did you contact a journalist?"
Claire's mouth was dry. She'd known this could happen. She'd thought she was ready for it. She wasn't.
"I sent an aggregate summary. Numbers only, no patient identifiers. I did it because the internal escalation channel routed to the same executive officer who approved the deployment."
The two trustees exchanged a look. Ruth Chen wrote something down.
"So you leaked," Mark said, almost gently. "You leaked sealed trial data to the press, and now you're asking this board to act on a report built from data of the same character. You understand the position you've put us in."
"The position I've put you in," Claire said, "is knowing that the device you're about to ship kills women at seven times the rate it kills men."
"That's enough." Prewitt took off her glasses. "Mr. Sorenson, do you have anything to add, or are you simply corroborating Ms. Bennett's account?"
Ethan stood. He didn't look at Mark. He looked at Prewitt.
"I reviewed the analysis independently. I ran the cohort split myself, twice, on a machine in the cardiac unit that has never touched Ms. Bennett's. I got the same number. Thirty-one percent." He paused. "My sister died in a hospital in Worcester because a physician read her chart and decided a thirty-two-year-old woman with chest pain was anxious. That was a human error, and it took a human being thirty seconds to make. Your algorithm makes that same error forty thousand times a day, and nobody's in the room to catch it."
The room didn't move.
"Dr. Sorenson," Mark said. "You're the trial's principal investigator. You're aware that your continued participation is contingent on—"
"I'm aware of what my participation is contingent on."
"Sit down, both of you," Prewitt said.
They sat.
What followed took eleven minutes. Mark talked about the Series C round, about the two hospital systems that had signed letters of intent, about the fact that pulling CardioSense now would trigger a material-adverse-event clause and put two hundred jobs at risk. Ruth Chen talked about the leaked email and the possibility of a regulatory inquiry, and how a voluntary pause wouldn't actually insulate the company from that. One of the trustees—the one with the silver hair—said, "You've raised a serious issue, Ms. Bennett. But I'm not hearing a path that doesn't involve lighting the company on fire."
"There's a path," Claire said. "A software patch. Re-weight the cohort, re-validate in ninety days, and issue a clinical advisory in the interim. We can do this without a recall."
"Ninety days is three fiscal quarters of revenue—"
"Ninety days is fourteen hospitals."
"We'll take the vote," Prewitt said.
Claire counted the hands. She counted them twice.
Seven to four. The motion to proceed with the launch as scheduled, with a commitment to "review the disparity findings in Q3."
Prewitt didn't look at her when she said it. That was the worst part. Prewitt looked at the table.
The room emptied fast after that. Ruth Chen gathered her papers. The silver-haired trustee shook Mark's hand on the way out. Mark didn't say anything to Claire at all—just closed his laptop and left, and somehow that was worse than a smirk.
Claire stood by the window with the harbor in front of her and her hands flat on the sill, and she couldn't make herself move.
Ethan came up beside her. He didn't touch her. He stood there, shoulder to shoulder, looking out at the water.
"I'm going to walk you out," he said.
"I leaked it. He was right."
"You told the truth to a reporter because telling it internally got routed to the man who's now congratulating himself in the hallway. That's not the same thing, and you know it."
"Do I?"
He turned to face her. "Look at me."
She did.
"I'm not resigning," he said. "And I'm not letting them bury this. Are you with me?"
Claire looked at the empty boardroom, at the seven chairs that had voted yes, at her own reflection in the glass—tired, diminished, still standing.
"Yes," she said.
They left together, and the door swung shut behind them on the world where they'd still believed the system might correct itself.